InsidersTradesSigma
Browse the complete record of transactions filed by El-Hibri Fuad, Director. Director active across 2 companies, notably Emergent BioSolutions Inc.. Cumulatively, 4 filings have been published. The latest transaction was disclosed on 3 December 2021 — J. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Fuad El-Hibri is a Board Member at Aptevo Therapeutics Inc. and Emergent BioSolutions Inc. In this role, he contributes to the strategic direction and governance of these companies, bringing his expertise in the biotechnology field.